docetaxel anhydrous has been researched along with Urinary Tract Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, A; Chaudhary, N; Kalia, M; Kant, V; Kaur, H; Modgil, V; Mohan, B; Singh, V; Taneja, N; Yadav, VK | 1 |
1 other study(ies) available for docetaxel anhydrous and Urinary Tract Infections
| Article | Year |
|---|---|
Repurposing of FDA approved drugs against uropathogenic Escherichia coli: In silico, in vitro, and in vivo analysis.
Topics: Animals; Anti-Bacterial Agents; Docetaxel; Drug Repositioning; Escherichia coli Infections; Humans; Mice; Molecular Docking Simulation; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |